Loading…
Roopa Industries (BSE 530991)₹43.96+0.71%Pharmaceuticals
In the Mar 2026 quarter (standalone), Roopa Industries reported sales of ₹30.11 Cr, up 1.0% from Mar 2025, and net profit of −₹1.44 Cr, down 434.9% year on year. For the year to Mar 2026, sales were ₹128 Cr and net profit ₹0 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14.93 | 14.14 | 19.21 | 22.07 | 34.50 | 25.58 | 30.68 | 29.81 | 35.06 | 28.73 | 33.51 | 30.11 |
| Expenses | 13.93 | 12.46 | 18.37 | 21.16 | 33.48 | 23.99 | 29.78 | 29.43 | 33.70 | 27.15 | 31.52 | 27.08 |
| Operating Profit | 1.02 | 1.69 | 0.87 | 0.92 | 1.04 | 1.63 | 0.96 | 0.43 | 1.41 | 1.62 | 2.03 | 3.08 |
| OPM % | 6.9% | 12.1% | 4.6% | 4.2% | 3.1% | 6.4% | 3.2% | 1.5% | 4.0% | 5.7% | 6.1% | 10.3% |
| Other Income | 0.00 | 0.03 | 0.39 | 0.72 | 0.23 | 0.00 | 0.93 | 1.13 | 0.03 | 0.00 | 0.00 | −3.97 |
| Interest | 0.55 | 0.68 | 0.69 | 0.67 | 0.78 | 0.70 | 0.66 | 0.65 | 0.85 | 0.82 | 0.78 | 0.73 |
| Depreciation | 0.22 | 0.22 | 0.22 | 0.18 | 0.19 | 0.19 | 0.25 | 0.18 | 0.19 | 0.18 | 0.18 | 0.20 |
| Profit before tax | 0.23 | 0.79 | 0.34 | 0.76 | 0.29 | 0.72 | 0.95 | 0.72 | 0.35 | 0.60 | 1.05 | −1.85 |
| Tax % | 20.9% | 25.1% | 25.8% | 39.0% | 10.1% | 19.3% | 20.9% | 43.9% | 25.1% | 24.7% | 26.5% | −23.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −3.98 |
| Net Profit | 0.18 | 0.61 | 0.28 | 0.47 | 0.28 | 0.59 | 0.75 | 0.43 | 0.27 | 0.47 | 0.78 | −1.44 |
| EPS (Rs) | 0.23 | 0.75 | 0.33 | 0.57 | 0.33 | 0.73 | 0.96 | 0.52 | 0.35 | 0.57 | 0.97 | −1.81 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.98 | 29.98 | 18.98 | 29.98 | 27.97 | 28.98 | 50.94 | 75.99 | 69.98 | 121 | 128 | 127 |
| Expenses | 31.01 | 28.03 | 22.01 | 28.02 | 26.01 | 26.01 | 48.05 | 72.01 | 66.03 | 117 | 119 | 119 |
| Operating Profit | −1.01 | 1.99 | −2.99 | 1.99 | 1.99 | 3.01 | 3.01 | 3.99 | 3.99 | 3.99 | 8.01 | 8.14 |
| OPM % | −2.8% | 7.0% | −13.9% | 8.1% | 7.1% | 10.1% | 7.1% | 5.0% | 6.0% | 3.4% | 6.1% | 6.4% |
| Other Income | 2.99 | 0.00 | 4.99 | 0.00 | 1.01 | 0.00 | 0.00 | 0.99 | 1.01 | 1.99 | −3.99 | −3.94 |
| Interest | 0.99 | 1.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 2.99 | 2.99 | 2.99 | 3.18 |
| Depreciation | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.75 |
| Profit before tax | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 1.99 | 2.99 | 0.00 | 0.15 |
| Tax % | 35.1% | 56.1% | −22.0% | 24.1% | 54.1% | 24.1% | 26.1% | 25.1% | 30.1% | 25.1% | 56.1% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −3.98 | −3.98 |
| Net Profit | 0.00 | 0.00 | 1.01 | 1.01 | 0.00 | 0.99 | 1.01 | 1.01 | 2.01 | 2.01 | 0.00 | 0.08 |
| EPS (Rs) | 0.21 | 0.23 | 0.68 | 0.75 | 0.46 | 0.91 | 1.29 | 1.71 | 1.92 | 2.57 | 0.09 | 0.08 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.01 | 8.01 | 8.01 | 8.01 | 8.01 | 8.01 | 8.01 | 8.01 | 8.02 | 8.01 | 8.01 | 8.01 |
| Reserves | 1.01 | 1.01 | 2.01 | 2.01 | 3.01 | 3.01 | 4.01 | 5.01 | 6.01 | 8.02 | 10.03 | 10.02 |
| Borrowings | 7.97 | 7.97 | 10.96 | 15.95 | 14.96 | 13.96 | 12.96 | 11.97 | 18.93 | 25.91 | 32.93 | 30.89 |
| Other Liabilities | 8.03 | 8.01 | 8.01 | 10.01 | 11.02 | 14.05 | 21.01 | 24.02 | 24.02 | 23.06 | 26.03 | 23.05 |
| Total Liabilities | 26.02 | 25.00 | 28.99 | 34.98 | 36.00 | 38.03 | 45.99 | 49.01 | 56.98 | 65.00 | 76.00 | 71.97 |
| Fixed Assets | 8.04 | 7.02 | 7.03 | 6.03 | 6.03 | 11.04 | 10.05 | 10.04 | 10.04 | 9.04 | 8.03 | 8.03 |
| CWIP | 0.00 | 0.00 | 0.00 | 1.99 | 3.99 | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 17.98 | 17.98 | 21.96 | 26.96 | 25.98 | 27.99 | 35.94 | 38.98 | 45.95 | 54.97 | 67.98 | 63.94 |
| Inventories | 8.02 | 4.41 | 7.09 | 9.24 | 10.62 | 12.33 | 19.44 | 15.31 | 18.36 | 25.14 | 36.10 | 30.78 |
| Trade receivables | 5.59 | 8.25 | 12.01 | 12.05 | 11.05 | 11.89 | 11.48 | 15.65 | 7.07 | 8.34 | 12.99 | 21.91 |
| Cash & equivalents | 0.68 | 0.74 | 0.72 | 0.61 | 0.76 | 0.72 | 0.99 | 2.02 | 2.72 | 4.14 | 4.63 | 1.55 |
| Total Assets | 26.02 | 25.00 | 28.99 | 34.98 | 36.00 | 38.03 | 45.99 | 49.01 | 56.98 | 65.00 | 76.00 | 71.97 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1.01 | 1.01 | −1.01 | −5.01 | 4.01 | 2.01 | −1.01 | 2.01 | 0.00 | 2.01 | −7.01 | 5.01 |
| Cash from investing activity | 0.00 | 0.00 | 0.00 | 2.01 | −2.01 | 1.01 | 1.01 | 4.01 | −1.01 | 1.01 | 2.01 | 0.00 |
| Cash from financing activity | 0.00 | −1.01 | 2.01 | 2.01 | −2.01 | −3.01 | −1.01 | −5.01 | 2.01 | −2.01 | 5.01 | −8.01 |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.99 | 0.00 | −2.99 |
| Capex | 0.17 | 0.17 | 0.38 | 2.41 | 2.69 | 0.51 | 0.73 | 0.85 | 1.38 | 0.80 | 0.86 | 0.52 |
| Free cash flow | 0.00 | 1.01 | −2.01 | −7.02 | 2.01 | 2.01 | −1.01 | 2.01 | −2.01 | 2.01 | −7.02 | 4.01 |
| CFO / OP % | 28.0% | −146.0% | −50.0% | 168.0% | 184.0% | 157.0% | −11.0% | 78.0% | 2.0% | 60.0% | −144.0% | 58.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 65 | 98 | 145 | 232 | 133 | 156 | 146 | 111 | 33 | 42 | 38 | 62 |
| Inventory days | 142 | 69 | 138 | 216 | 170 | 255 | 408 | 139 | 108 | 167 | 120 | 101 |
| Days payable | 133 | 101 | 123 | 178 | 124 | 220 | 281 | 87 | 43 | 97 | 57 | 42 |
| Cash conversion cycle | 76 | 68 | 163 | 272 | 181 | 193 | 276 | 165 | 100 | 115 | 103 | 122 |
| Working capital days | 33 | 70 | 115 | 215 | 109 | 105 | 115 | 38 | 2 | 11 | 37 | 33 |
| ROCE % | 10.0% | 10.0% | 10.0% | 6.0% | 9.0% | 9.0% | 8.0% | 10.0% | 13.0% | 12.0% | 12.0% | 15.0% |
For the Mar 2026 quarter, Roopa Industries reported sales of ₹30.11 Cr, up 1.0% year on year and net profit of −₹1.44 Cr, down 434.9% year on year. The operating margin was 10.3%.
Roopa Industries' sales for the year to Mar 2026 were ₹128 Cr; over the last twelve months they were ₹127 Cr.
Net profit for the year to Mar 2026 was ₹0 Cr, and ₹0.08 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.08.
Roopa Industries reported borrowings of ₹30.89 Cr at Mar 2026, against cash and equivalents of ₹1.55 Cr.
Cash from operations was ₹5.01 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹4.01 Cr.